1. Home
  2. BLIV vs OKUR Comparison

BLIV vs OKUR Comparison

Compare BLIV & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLIV
  • OKUR
  • Stock Information
  • Founded
  • BLIV 2014
  • OKUR 2011
  • Country
  • BLIV Singapore
  • OKUR United States
  • Employees
  • BLIV N/A
  • OKUR N/A
  • Industry
  • BLIV
  • OKUR
  • Sector
  • BLIV
  • OKUR
  • Exchange
  • BLIV NYSE
  • OKUR NYSE
  • Market Cap
  • BLIV 39.8M
  • OKUR 34.9M
  • IPO Year
  • BLIV 2025
  • OKUR N/A
  • Fundamental
  • Price
  • BLIV $4.33
  • OKUR $2.53
  • Analyst Decision
  • BLIV
  • OKUR Strong Buy
  • Analyst Count
  • BLIV 0
  • OKUR 4
  • Target Price
  • BLIV N/A
  • OKUR $32.25
  • AVG Volume (30 Days)
  • BLIV 154.8K
  • OKUR 333.1K
  • Earning Date
  • BLIV 01-01-0001
  • OKUR 05-06-2025
  • Dividend Yield
  • BLIV N/A
  • OKUR N/A
  • EPS Growth
  • BLIV N/A
  • OKUR N/A
  • EPS
  • BLIV N/A
  • OKUR N/A
  • Revenue
  • BLIV $1,355,200.00
  • OKUR N/A
  • Revenue This Year
  • BLIV N/A
  • OKUR N/A
  • Revenue Next Year
  • BLIV N/A
  • OKUR N/A
  • P/E Ratio
  • BLIV N/A
  • OKUR N/A
  • Revenue Growth
  • BLIV N/A
  • OKUR N/A
  • 52 Week Low
  • BLIV $2.69
  • OKUR $1.70
  • 52 Week High
  • BLIV $6.40
  • OKUR $20.00
  • Technical
  • Relative Strength Index (RSI)
  • BLIV N/A
  • OKUR N/A
  • Support Level
  • BLIV N/A
  • OKUR N/A
  • Resistance Level
  • BLIV N/A
  • OKUR N/A
  • Average True Range (ATR)
  • BLIV 0.00
  • OKUR 0.00
  • MACD
  • BLIV 0.00
  • OKUR 0.00
  • Stochastic Oscillator
  • BLIV 0.00
  • OKUR 0.00

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: